MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer

Abstract Background The long non-coding RNA (lncRNA), MALAT1, plays a key role in the development of different cancers, and its expression is associated with worse prognosis in patients. However, its mechanism of action and its regulation are not well known in prostate cancer (PCa). A general mechan...

Full description

Bibliographic Details
Main Authors: Carmela Ferri, Anna Di Biase, Marco Bocchetti, Silvia Zappavigna, Sarah Wagner, Pauline Le Vu, Amalia Luce, Alessia Maria Cossu, Jayakumar Vadakekolathu, Amanda Miles, David J. Boocock, Alex Robinson, Melanie Schwerdtfeger, Virginia Tirino, Federica Papaccio, Michele Caraglia, Tarik Regad, Vincenzo Desiderio
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-021-02233-w
_version_ 1818752829130539008
author Carmela Ferri
Anna Di Biase
Marco Bocchetti
Silvia Zappavigna
Sarah Wagner
Pauline Le Vu
Amalia Luce
Alessia Maria Cossu
Jayakumar Vadakekolathu
Amanda Miles
David J. Boocock
Alex Robinson
Melanie Schwerdtfeger
Virginia Tirino
Federica Papaccio
Michele Caraglia
Tarik Regad
Vincenzo Desiderio
author_facet Carmela Ferri
Anna Di Biase
Marco Bocchetti
Silvia Zappavigna
Sarah Wagner
Pauline Le Vu
Amalia Luce
Alessia Maria Cossu
Jayakumar Vadakekolathu
Amanda Miles
David J. Boocock
Alex Robinson
Melanie Schwerdtfeger
Virginia Tirino
Federica Papaccio
Michele Caraglia
Tarik Regad
Vincenzo Desiderio
author_sort Carmela Ferri
collection DOAJ
description Abstract Background The long non-coding RNA (lncRNA), MALAT1, plays a key role in the development of different cancers, and its expression is associated with worse prognosis in patients. However, its mechanism of action and its regulation are not well known in prostate cancer (PCa). A general mechanism of action of lncRNAs is their interaction with other epigenetic regulators including microRNAs (miRNAs). Methods Using lentiviral stable miRNA transfection together with cell biology functional assays and gene expression/target analysis, we investigated the interaction between MALAT1 and miR-423-5p, defined as a target with in silico prediction analysis, in PCa. Results Through bioinformatic analysis of data available from TCGA, we have found that MALAT1 expression correlates with high Gleason grade, metastasis occurrence, and reduced survival in PCa patients. These findings were validated on a TMA of PCa showing a significant correlation between MALAT1 expression with both stage and grading. We report that, in PCa cells, MALAT1 expression and activity is regulated by miR-423-5p that binds MALAT1, downregulates its expression and inhibits its activity in promoting proliferation, migration, and invasion. Using NanoString analysis, we unraveled downstream cell pathways that were affected by miR-423-5p expression and MALAT1 downregulation and identified several alterations in genes that are involved in metastatic response and angiogenic pathways. In addition, we showed that the overexpression of miR-423-5p increases survival and decreases metastases formation in a xenograft mouse model. Conclusions We provide evidence on the role of MALAT1 in PCa tumorigenesis and progression. Also, we identify a direct interaction between miR-423-5p and MALAT1, which results in the suppression of MALAT1 action in PCa.
first_indexed 2024-12-18T04:57:41Z
format Article
id doaj.art-6775aa52ba8e4162a369ebbfb370a0a7
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-18T04:57:41Z
publishDate 2022-01-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-6775aa52ba8e4162a369ebbfb370a0a72022-12-21T21:20:14ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662022-01-0141111610.1186/s13046-021-02233-wMiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancerCarmela Ferri0Anna Di Biase1Marco Bocchetti2Silvia Zappavigna3Sarah Wagner4Pauline Le Vu5Amalia Luce6Alessia Maria Cossu7Jayakumar Vadakekolathu8Amanda Miles9David J. Boocock10Alex Robinson11Melanie Schwerdtfeger12Virginia Tirino13Federica Papaccio14Michele Caraglia15Tarik Regad16Vincenzo Desiderio17Department of Precision Medicine, University of Campania “Luigi Vanvitelli”The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent UniversityDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”Department of Precision Medicine, University of Campania “Luigi Vanvitelli”The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent UniversityClinical and Experimental Sciences, Faculty of Medicine, Southampton General Hospital, University of SouthamptonDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic ResearchThe John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent UniversityThe John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent UniversityThe John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent UniversityDepartment of Life Sciences, Faculty of Health, Education and Life Sciences, Birmingham City UniversityDepartment of Experimental Medicine, University of Campania “Luigi Vanvitelli”Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of SalernoDepartment of Precision Medicine, University of Campania “Luigi Vanvitelli”Department of Precision Medicine, University of Campania “Luigi Vanvitelli”Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”Abstract Background The long non-coding RNA (lncRNA), MALAT1, plays a key role in the development of different cancers, and its expression is associated with worse prognosis in patients. However, its mechanism of action and its regulation are not well known in prostate cancer (PCa). A general mechanism of action of lncRNAs is their interaction with other epigenetic regulators including microRNAs (miRNAs). Methods Using lentiviral stable miRNA transfection together with cell biology functional assays and gene expression/target analysis, we investigated the interaction between MALAT1 and miR-423-5p, defined as a target with in silico prediction analysis, in PCa. Results Through bioinformatic analysis of data available from TCGA, we have found that MALAT1 expression correlates with high Gleason grade, metastasis occurrence, and reduced survival in PCa patients. These findings were validated on a TMA of PCa showing a significant correlation between MALAT1 expression with both stage and grading. We report that, in PCa cells, MALAT1 expression and activity is regulated by miR-423-5p that binds MALAT1, downregulates its expression and inhibits its activity in promoting proliferation, migration, and invasion. Using NanoString analysis, we unraveled downstream cell pathways that were affected by miR-423-5p expression and MALAT1 downregulation and identified several alterations in genes that are involved in metastatic response and angiogenic pathways. In addition, we showed that the overexpression of miR-423-5p increases survival and decreases metastases formation in a xenograft mouse model. Conclusions We provide evidence on the role of MALAT1 in PCa tumorigenesis and progression. Also, we identify a direct interaction between miR-423-5p and MALAT1, which results in the suppression of MALAT1 action in PCa.https://doi.org/10.1186/s13046-021-02233-wProstateCancermiRNAslncRNAsmiR-423-5pMalat-1
spellingShingle Carmela Ferri
Anna Di Biase
Marco Bocchetti
Silvia Zappavigna
Sarah Wagner
Pauline Le Vu
Amalia Luce
Alessia Maria Cossu
Jayakumar Vadakekolathu
Amanda Miles
David J. Boocock
Alex Robinson
Melanie Schwerdtfeger
Virginia Tirino
Federica Papaccio
Michele Caraglia
Tarik Regad
Vincenzo Desiderio
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
Journal of Experimental & Clinical Cancer Research
Prostate
Cancer
miRNAs
lncRNAs
miR-423-5p
Malat-1
title MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
title_full MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
title_fullStr MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
title_full_unstemmed MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
title_short MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer
title_sort mir 423 5p prevents malat1 mediated proliferation and metastasis in prostate cancer
topic Prostate
Cancer
miRNAs
lncRNAs
miR-423-5p
Malat-1
url https://doi.org/10.1186/s13046-021-02233-w
work_keys_str_mv AT carmelaferri mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT annadibiase mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT marcobocchetti mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT silviazappavigna mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT sarahwagner mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT paulinelevu mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT amalialuce mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT alessiamariacossu mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT jayakumarvadakekolathu mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT amandamiles mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT davidjboocock mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT alexrobinson mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT melanieschwerdtfeger mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT virginiatirino mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT federicapapaccio mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT michelecaraglia mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT tarikregad mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer
AT vincenzodesiderio mir4235ppreventsmalat1mediatedproliferationandmetastasisinprostatecancer